Cargando…

High expression of Aldolase A predicts poor survival in patients with clear-cell renal cell carcinoma

BACKGROUND: Aldolase A (ALDOA) is a glycolytic enzyme that drives the glycolytic metabolic pathway in mammalian cells. The overexpression of ALDOA was observed in a variety of cancers including clear-cell renal cell carcinoma (ccRCC). However, little was known about the clinicopathological significa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Na, Ning, Li, Heng, Xu, Chengfang, Miao, Bin, Hong, Liangqing, Huang, Zhengyu, Jiang, Qiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338975/ https://www.ncbi.nlm.nih.gov/pubmed/28280347 http://dx.doi.org/10.2147/TCRM.S123199

Ejemplares similares

High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma
por: Na, Ning, et al.
Publicado: (2016)

Meta-analysis of the efficacy of the pretreatment neutrophil-to-lymphocyte ratio as a predictor of prognosis in renal carcinoma patients receiving tyrosine kinase inhibitors
por: Na, Ning, et al.
Publicado: (2016)

Renoprotective effect of erythropoietin via modulation of the STAT6/MAPK/NF-κB pathway in ischemia/reperfusion injury after renal transplantation
por: Zhang, Jinhua, et al.
Publicado: (2018)

Low Expression of MATR3 Is Associated with Poor Survival in Clear Cell Renal Cell Carcinoma
por: Durślewicz, Justyna, et al.
Publicado: (2023)

Radiomics Analysis of Contrast-Enhanced CT Predicts Survival in Clear Cell Renal Cell Carcinoma
por: Yan, Lei, et al.
Publicado: (2021)

Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
por: Chen, Lujun, et al.
Publicado: (2019)

Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma
por: Wang, Song, et al.
Publicado: (2021)

ASNS can predict the poor prognosis of clear cell renal cell carcinoma
por: Gan, Xinqiang, et al.
Publicado: (2022)

Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinoma
por: Chen, Siteng, et al.
Publicado: (2022)

Use of Serum Gamma‐enolase and Aldolase A in Combination as Markers for Renal Cell Carcinoma
por: Takashi, Munehisa, et al.
Publicado: (1993)

High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wang, Xuegang, et al.
Publicado: (2023)

The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma
por: Huang, Jian, et al.
Publicado: (2022)

Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
por: Zhengqi, Qiu, et al.
Publicado: (2021)

MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis
por: Xiao, Haibing, et al.
Publicado: (2015)

Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome
por: Xue, Yi-Jun, et al.
Publicado: (2019)

FCGR2A as one novel potential target for poor survival prognosis of clear cell renal cell carcinoma
por: Fu, Taozhu, et al.
Publicado: (2023)

Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis
por: Xiao, Haibing, et al.
Publicado: (2019)

Redox Metabolism-Associated Molecular Classification of Clear Cell Renal Cell Carcinoma
por: Wei, Xiangling, et al.
Publicado: (2022)

Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma
por: Long, Zhilin, et al.
Publicado: (2022)

Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Gao, Yuan, et al.
Publicado: (2020)

Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial
por: Sun, Qipeng, et al.
Publicado: (2018)

Decreased Expression of GLYATL1 Predicts Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma
por: Deng, Limin, et al.
Publicado: (2023)

Influence of gene expression on survival of clear cell renal cell carcinoma
por: Berglund, Anders, et al.
Publicado: (2020)

Survival benefit of pancreatic metastasectomy of clear cell renal cell carcinoma
por: Fang, Yuan, et al.
Publicado: (2019)

Rab25 expression predicts poor prognosis in clear cell renal cell carcinoma
por: LIU, LUNZHI, et al.
Publicado: (2014)

Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2019)

Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wu, Jun, et al.
Publicado: (2021)

Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Liu, Xianhui, et al.
Publicado: (2022)

Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Kurota, Yuta, et al.
Publicado: (2023)

Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma
por: Zhang, Zhi-Cheng, et al.
Publicado: (2023)

High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma
por: Wang, Jieti, et al.
Publicado: (2016)

High expression of F2RL3 correlates with aggressive features and poor survival in clear cell renal cell carcinoma
por: Cao, Dalong, et al.
Publicado: (2018)

TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients’ survival
por: Xiao, Wen, et al.
Publicado: (2018)

Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma
por: Yu, Deshui, et al.
Publicado: (2022)

Identification of hub genes associated with outcome of clear cell renal cell carcinoma
por: Li, Rengui, et al.
Publicado: (2020)

Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma
por: Qiu, Jiechuan, et al.
Publicado: (2023)

Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma
por: Mu, Zhongyi, et al.
Publicado: (2020)

Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma
por: Gao, Lei, et al.
Publicado: (2020)

Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma
por: WANG, WEI, et al.
Publicado: (2014)

Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma
por: Song, Zhengshuai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cgs0dv1jnvp8vbrmd8cm55k2b0